Announces Pharmaceutical Contract Manufacturing Agreement
10/09/2026 08:12
BRIEF-Samsung Biologics Co.,Ltd. - Announces Pharmaceutical Contract Manufacturing Agreement SAMSUNG BIOLOGICS CO.,LTD. 207940.KS:
SAMSUNG BIOLOGICS CO.,LTD. - CONTRACT VALUE IS WON 350.77 BILLION
SAMSUNG BIOLOGICS CO.,LTD. - ANNOUNCES PHARMACEUTICAL CONTRACT MANUFACTURING AGREEMENT
Source text: [ID:]
Further company coverage: 207940.KS
Recent news on SAMSUNG BIOLOGICS
See all newsSouth Korean shares log 6-month closing low as chipmakers fall on profit-taking
South Korean shares fall on profit taking; BOK in focus
South Korean shares post biggest gain in 6 weeks as chipmakers rebound
South Korean shares fall nearly 3% as AI concerns hit chipmakers
South Korean shares start week lower on AI worries